Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome (Q31871576)

4 July 2017

Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome (English)

1 reference

4 July 2017

0 references

Nisijima K

1

1 reference

4 July 2017

Yoshino T

series ordinal

2

1 reference

4 July 2017

Yui K

series ordinal

3

1 reference

4 July 2017

Katoh S

series ordinal

4

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

4 July 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

4 July 2017

890

1 reference

4 July 2017

1

1 reference

4 July 2017

23-31

1 reference

5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Efficacy and adverse effects of moclobemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Prenatal exposure of rats to antidepressant drugs down-regulates beta-adrenoceptors and 5-HT2 receptors in cerebral cortex. Lack of correlation between 5-HT2 receptors and serotonin-mediated behaviour.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

The serotonin syndrome and its treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Treatment of the serotonin syndrome with cyproheptadine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Serotonin syndrome and drug combinations: focus on MAOI and RIMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Treatment of the serotonin syndrome with cyproheptadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Blockade of NMDA receptor-mediated mobilization of intracellular Ca2+ prevents neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Analysis of serial measurements in medical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Serotonin syndrome. A clinical update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Death by "ecstasy": the serotonin syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Risperidone counteracts lethality in an animal model of the serotonin syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

The response pattern of noradrenaline release to repeated stress in the hypothalamic paraventricular nucleus differs according to the form of stress in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

7 January 2021

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Basal and stress-induced release of noradrenaline in hypothalamus of spontaneously hypertensive rats at different ages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Dantrolene protects against ischemic, delayed neuronal death in gerbil brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

Successful treatment of the toxic serotonin syndrome with chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903020-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(00)03020-1

1 reference

4 July 2017

1 reference